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Abstract
Background: Dimeticone 4% lotion is an effective and widely accepted treatment for head louse infestation.
However, it is a highly mobile fluid that some people find difficult to apply and is mainly left on the hair for
8 hours or overnight. User preference is for a more manageable and viscous product that can be used with a short
application time.
Findings: This proof of concept study in 41 people investigated dimeticone 4% liquid gel, a product that is easier
to apply than the lotion, applied for 15 minutes on two occasions a week apart. We found that head lice were
eliminated from all participants following the first application of product. We did not find lice of any stage on any
participant during four post treatment assessments and particularly, unlike other treatments, no young nymphs on
days 1 and 6 prior to the second treatment, indicating ovicidal as well as pediculicidal activity.
Conclusions: Dimeticone 4% liquid gel has demonstrated efficacy greater than other similar products and the
evidence obtained indicates elimination of head louse infestation with a single 15 minute application.
Trial registration: Current Controlled Trials ISRCTN59227204
Background
Dimeticone 4% lotion is a physically acting pediculicide
based on 4% high molecular weight dimeticone in a cyclo-
methicone base. Since its introduction in 2006, dimeticone
4% lotion (Hedrin
® 4% lotion) has become a market-
leading product in several countries. Early studies showing
equivalence with or superiority to insecticide products
[1,2] were not received enthusiastically by some commen-
tators because the cure rate of around 70% was considered
less than optimum [3,4]. The rate of successful treatment
in these studies was lower than expected at least partly
due to rapid reinfestation of participants because relatively
few individuals were treated in each community, many of
which had a high prevalence of infestation. A more recent
study involving whole communities in Turkey showed
improved efficacy above 90% [5].
All previous investigations, and consumer feedback,
have noted the fluid mobility of dimeticone 4% lotion
and a readiness of the product to drip from some hair
types. It is possible that flow of the lotion away from
the roots of the hair may have influenced the treatment
outcome on some trial participants if insufficient pro-
duct remained in contact with lice and especially louse
eggs. In response to discussions of this problem a more
viscous preparation, Hedrin
® 4% liquid gel, was devel-
oped by the manufacturer (Thornton & Ross Ltd, UK).
The new liquid gel product was initially evaluated by
our group in a proof of concept study using a 1 hour
application time [IFB, NAB, ER Brunton, unpublished
data]. In this study, we found the liquid gel eliminated
infestation from more than 95% of the participants. In
response to further feedback from consumers wishing
for a shorter application time, this study was designed
to determine whether the product is as effective using a
reduced application time of 15 minutes.
Study design
This was a single-centre, non-randomised, single-arm
proof of concept study conducted in conformity with
the principles of Good Clinical Practice and the Declara-
tion of Helsinki. Ethical approval was granted by Shef-
field Research Ethics Committee, reference 10/H1308/7.
All procedures were performed during visits to partici-
pants at home using essentially the same methods
described in previous studies [1,2]. We confirmed that
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detection combing prior to treatment on day 0. We did
not count lice or louse eggs on each person at the time
of enrolment but measured the level of infestation by
the rapidity of finding lice during combing. Participants
confirmed they had not been treated with pediculicides
for 2 weeks or with antibiotics or hair dyes for 4 weeks,
were asked about possible allergies or sensitivities to
treatment, and provided informed consent prior to
entry. We assessed for possible persistence of infestation
using a plastic head louse detection comb (PDC, KSL
Consulting, Denmark) during follow-up visits on days 1
and 6 between treatments. On each occasion, the person
was combed systematically for several minutes with
actual time dependent upon hair length and thickness.
The protocol required a second treatment to be applied
to all participants on day 7 irrespective of whether lice
had been found, with further combing checks for lice
using the PDC on days 11 and 14 to confirm outcome
of treatment.
Study results
The study enrolled 41 participants from 19 families, with
ages ranging from 2 - 44 (median 10 years), between 4
th
March and 17
th May 2010. Of these 30 (73%) were female.
The age structure of this cohort was non-significantly dif-
ferent from previous studies, but did have a smaller pro-
portion (7/41, 17.1%) in the 6-9 years age group compared
with 1-5 years (10/41, 24.2%) and 10-15 years (16/41,
39.0%) than in most previous studies. Other demographic
characteristics such as hair length, thickness, degree of
curl, and dryness/greasiness were similar to groups
observed in previous studies. The level of infestation
(heavy infestation = >1 louse with one stroke of the comb;
moderate infestation = 1 louse with one stroke of the
comb; light infestation = first louse found after several
strokes of the comb), was significantly (p = 0.0295) higher
with respect to heavy and moderate infestations than
found in the previous investigation of liquid gel
(ISRCTN50373146), using a 1 hour application of product.
Using these criteria, we found eight cases of heavy infesta-
tion, 13 of moderate infestation, and the remainder were
light infestations. However, in most cases, the actual inten-
sity of infestation was greater than indicated by this semi-
subjective measure and all participants had more than
10 viable eggs in their hair. There was no identifiable rela-
tionship between intensity of infestation and hair length or
thickness. Most participants either reported seeing lice in
rinsing water while washing out the treatment or found
the dead bodies of lice on the pillow or during grooming
the morning following treatment.
Follow up detection combing of participants is designed
to not only measure the initial therapeutic impact of
treatment on the infestation but also to look for newly
emerged nymphs, which would have emerged from eggs
not killed by the treatment. Detection combing of partici-
pants after treatment in this study was unable to find live
lice of any stage on anyone following the first application
of dimeticone 4% liquid gel. Unlike all previous studies
(Table 1), no nymphal lice were found during the week
following treatment, indicating that all louse eggs were
prevented from hatching by the first treatment application.
There were no adverse events related to treatment and
no serious adverse events. The 8 reported adverse events
in five people included 3 lower limb injuries (2 bruised
heels from poorly supported trainer shoes, one broken
tibia after falling from a trampoline), one case of hand
injuries from using crutches, a prescheduled overnight
stay in hospital followed by a photocoagulation opera-
tion for endometriosis, and 2 incidents of listlessness
and loss of appetite after returning from school, both of
which passed within a few hours.
The only apparent drawback for this treatment regi-
men was that after treatment 35/41 (85.4%) participants
found the product more difficult to wash out than some
other preparations and 32 (70.1%) found their hair felt
more oily than normal. However, all the 38 who had
had prior experience of using dimeticone-based prepara-
tions expressed a preference for using the liquid gel,
based on its level of efficacy and the convenient applica-
tion time.
Discussion
We have found that Hedrin 4% dimeticone liquid gel
applied for 15 minutes not only eliminated all cases of
head louse infestation, using the standard approach to
treatment of two applications a week apart, but also
eliminated all mobile stages and inhibited any emergence
of louse nymphs from eggs following the first treatment.
Various silicone formulations for control of head lice
are now available, mainly on European markets. Two
widely used dimeticone based preparations, Hedrin
®
4% lotion (Thornton & Ross Ltd, Huddersfield, UK)
and Nyda
® L (G. Pohl-Boskamp GmbH & Co. KG,
Hohenlockstedt, Germany) both employ an 8 hour or
overnight application but neither have shown either
complete eradication of infestation or complete inhibi-
tion of louse egg hatching in the clinical evaluations
conducted so far [1,2,5,6]. Both these preparations are
designed to evaporate during the treatment process,
which means that the majority of the fluid applied is
the less active solvent material in the product. Conse-
quently, although the hair may appear to be saturated
it may not be adequately coated with product, which
reduces the likelihood of killing louse eggs. In contrast,
the liquid gel employs a non-volatile vehicle based on
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co-polymer with silica silylate thickener, plus 1,6,10-
dodecatrien-3-ol,3,7,11-trimethyl as a surface tension
modifier. None of these components has any specific
activity against lice other than to reduce flow of the
material along hair shafts and to facilitate adhesion of
the dimeticone to the louse or louse egg surface.
In therapeutic terms, killing lice is relatively easy and
the introduction of physically acting materials such as
dimeticone has greatly facilitated elimination of both
adult and nymphal lice from both individuals and the
community. However, consistent prevention of egg hatch
was always a difficult goal to achieve even before the evo-
lution of resistance to neurotoxic insecticides because
most insecticide based products were not ovicidal. A few
were able to penetrate the chorionic membrane through
use of monoterpene components [7,8] and some others,
although unable to kill the embryos, were able to prevent
nymphs from hatching or surviving through deposition
of residual insecticide on eggs and hairs that killed the
insects after emergence [9]. Nevertheless, no product in
the past could be considered reliably effective to kill all
lice and eggs with a single application.
In the case of the liquid gel, unlike some other dimeti-
cone based lotions, there is no volatile component so
louse eggs should be thoroughly coated during the treat-
ment process. Also, because some components of the
product were found to be more difficult to wash out, it
appears a residue of active material remains on the hairs,
lice, and louse eggs even after most of the product has
been removed with shampoo. We believe this coating
occludes the respiratory structures of the insects and
their eggs long past the actual treatment phase. In the
case of lice, the physical occlusion due to high molecular
weight dimeticone has been shown to disrupt water man-
agement [10]. However, louse eggs need to retain water
rather than eliminate it. Prolonged contact with silicone
would permit the low surface tension material to flow
throughout the aeropyle structure and allowing contact
between the silicone and the chorionic membrane.
In vitro studies have indicated that this is facilitated by
the 1,6,10-dodecatrien-3-ol,3,7,11-trimethyl (Penetrol™)
component of the liquid gel but this component did not
appear to contribute to treatment outcome for the lotion
formulation in one clinical study [5]. Prolonged contact
of silicone with the egg would result in two effects. First,
the physical plug of dimeticone in the complex capillary
tubes of the aeropyle structure would limit gaseous
exchange, despite the relative gas permeability of silox-
anes. Additionally there could be some lipid disruption of
the chorionic membrane so that it would be less protec-
tive of the louse embryo, especially as it nears the point
of hatching.
This study has shown an improved outcome of treat-
ment using dimeticone 4% liquid gel than any previous
study of a siloxane based product. Effective use of the
product in communities where previous investigations
using other treatments have been less effective gives
confidence that our results are likely to be generalisable
to a wider community, and feedback from study partici-
pants and other contacts using the product suggests this
is the case. The result is encouraging and indicates that
coordinated treatments using Hedrin
® 4% liquid gel, in
a similar manner to the way we used dimeticone 4%
lotion in our study in Turkey [5], could reduce the bur-
den of louse infestation in communities more effectively
than using less predictably effective lotion preparations.
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Table 1 Comparison of reported numbers of participants found with lice and with louse nymphs following first
treatment using different dimeticone based products
Study Lice present before day 7 Percent Nymphs present before day 7 Percent Probability
Hedrin lotion overnight [1] * 91/127 71.6 86/127 67.7 a
ISRCTN47755726 Hedrin lotion overnight [2] * 32/43 74.4 27/43 62.8 a
ISRCTN15117709 Nyda L lotion overnight [6] ** 26/73 35.6 Data not available - b
ISRCTN50373146 Hedrin liquid gel 1 hour * 3/42 7.1 2/42 4.8 c
ISRCTN59227204 Hedrin liquid gel 15 min 0/41 0.0 0/41 0.0 c
* Treatments used with two applications 7 days apart.
** Treatment instructions originally recommended two applications with combing but now indicate one application may be effective with a repeat after 8 days if
lice persist.
Probability: Differences between groups were determined using Fisher’s exact test. Groups with the same letter were not significantly different from each other.
Differences were detected between groups ‘a’ and ‘b’ (p < 0.001) and groups ‘b’ and ‘c’ (p < 0.001).
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